A study protocol for assessing the efficacy of add-on Brihatkataphaladi Vati, Vasadi Kashaya and polyherbal nebulization in the management of chronic obstructive pulmonary disease: a randomized placebo-controlled clinical trial

Maya Darji; Mandip R. Goyal

doi:10.18203/2349-3259.ijct20263761

Authors

Maya Darji Department of Kayachikitsa, Institute of Teaching and Research in Ayurveda, Jamnagar, Gujarat, India
Mandip R. Goyal Department of Kayachikitsa, Institute of Teaching and Research in Ayurveda, Jamnagar, Gujarat, India

DOI:

https://doi.org/10.18203/2349-3259.ijct20263761

Keywords:

Ayurveda, Brihatkataphaladi Vati, COPD, Polyherbal nebulization, Tamaka Shwasa, Vasadi Kashaya

Abstract

Background: Chronic obstructive pulmonary disease (COPD), correlated with Tamaka Shwasa in Ayurveda, is a major global health concern characterized by persistent airflow obstruction. Conventional treatment provides symptomatic relief and reduces exacerbations but has limited effects on disease progression. Ayurveda interventions with potential anti-inflammatory, mucolytic, and broncho-dilatory properties may offer complementary benefits. This study aims to evaluate the efficacy and safety of add-on Brihatkataphaladi Vati, Vasadi Kashaya, and polyherbal nebulization alongside standard care in COPD.

Methods: This randomized, placebo-controlled, parallel-group clinical trial will include 50 clinically stable COPD patients classified as GOLD Grades I-III. Participants will be randomly allocated into two groups of 25 each. The intervention group will receive Brihatkataphaladi Vati, Vasadi Kashaya, and polyherbal nebulization alongside standard care, whereas the control group will receive placebo alongside standard care. Treatment will continue for 90 days, with weekly follow-ups and two post-treatment follow-up visits. The primary outcome will be the change in COPD symptom severity measured using the COPD assessment test (CAT) score. Secondary outcomes will include changes in forced expiratory volume in one second (FEV₁), FEV₁/FVC ratio, exacerbation and hospitalization frequency, rescue medication use, Ayurvedic symptom scores, and safety parameters assessed through clinical monitoring and laboratory investigations. Outcomes will be assessed at baseline and post-treatment. Appropriate statistical tests will be applied, with p<0.05 considered statistically significant.

Conclusions: The study is expected to provide evidence regarding the efficacy and safety of this integrative therapeutic approach in improving symptoms and pulmonary function in COPD patients.

Trial Registration: The trial is registered with Clinical trial registry of India (CTRI) CTRI/2026/05/110230.

References

American Lung Association. Learn about COPD. Available at: https://www.lung.org/lung-health-diseases/lung-disease-lookup/copd/learn-about-copd. Accessed on 22 June 2026.

Global Initiative for Chronic Obstructive Lung Disease. 2022 Global Strategy for Prevention, Diagnosis and Management of COPD. www.goldcopd.org. Accessed on 22 June 2026.

Pahal P, Avula A, Afzal M. Emphysema (Archived). In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2026.

Wang Z, Lin J, Liang L, Feifei H, Xiaoyin Y, Kang P, et al. Global, regional, and national burden of chronic obstructive pulmonary disease and its attributable risk factors from 1990 to 2021: an analysis for the Global Burden of Disease Study 2021. Respirat Res. 2025;26(1):2.

Shastri KN, Chaturvedi GN. Agnivesha’s Charaka Samhita, Vidyotini Commentary In: Chikitsasthana, 17/5, Varanasi: Choukhambha Bharti Academy. 2009;508.

Kaviraja Ambikadutta Shastri.Sushruta Samhita with Ayurveda- Tatva- Sandipika part 2, Uttartantra 51/4, Varanasi:Choukhambha Sanskrit Sansthan. 2016;475

Chakrapani. Charaka Samhita of Charaka with Ayurveda Dipika commentary Chikitsasthana 17/55-60. Delhi: Rastriya Sanskrit Sansthana. 2006;533-5.

Verma A, Gudi N, Yadav UN, Roy MP, Mahmood A, Nagaraja R, et al. Prevalence of COPD among population above 30 years in India: A systematic review and meta-analysis. J Global Health. 2001;11:04038.

Jones PW, Harding G, Wiklund I, Berry P, Leidy NK, Chen WH. Development and first validation of the COPD Assessment Test. Euro Resp J. 2009;34(3):648-654.

Baghel MS, Rajagopala S. Developing Guidelines for Clinical Research Methodology in Ayurveda. Jamnagar: Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University. 2011: 13-16.

Nasreen A, Divya K, Deepak B. Evaluating Clinical Efficacy of Ayurvedic Inhalation Therapy (Aerosol) and Rasayan Therapy in the Management of COPD-A Randomized Cohort Control Clinical Study. Nasreen, Ahmed and Kajaria Divya. Int J Ayurveda Pharma Res. 2019: 49-54.

Global strategy for prevention, diagnosis and management of COPD: 2024 Report Available at: https://goldcopd.org/2024-gold-report/. Accessed on 22 June 2026.